PS
Insider
Paul Sagan
DirectorPaul Sagan (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Moderna, Inc. (MRNA). Across 1 priced purchase filing, the average 21-session return was -9.1% from execution and -8.8% from disclosure (delay-adjusted; derived). The largest single filing was $1.0M of MRNA (31,620 sh × $31.76, as filed), executed Mar 3 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-9.1%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-8.8%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.0M
shares × price, as filed
Last traded
Mar 3 2025
Filed Mar 4 2025
Median ADV $1.0B across their filed names
Open performance→Volume by month
Buys $1.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
MRNARecent filings
MRNAPURCHASE
Moderna, Inc.
View filing →
$1.0M31,620 sh × $31.76
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET